Highland Hospital is located in Rochester, New York, and is an affiliate of the University of Rochester Medical Center, which is part of the University of Rochester. Founded in 1889, the hospital is involved in specialties such as bariatric surgery, joint replacement, geriatric care, women's services and maternity.

There are 261 beds in Highland Hospital.

During the past decade, Highland Hospital conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 59 clinical trials were completed, i.e. on average, 168.6% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 24 clinical trials were completed. i.e. 141.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Highland Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 32 trials, followed by "SWOG Cancer Research Network" with 27 trials sponsored, "Radiation Therapy Oncology Group" with 24 trials sponsored, "NRG Oncology" with 13 trials sponsored and "Alliance for Clinical Trials in Oncology" with 13 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Highland Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 87 trials as a collaborator, "NRG Oncology" with 32 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "North Central Cancer Treatment Group" with 6 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Highland Hospital" are "Breast Cancer" (18 trials), "Lung Cancer" (12 trials), "Prostate Cancer" (6 trials), "Recurrent Squamous Cell Lung Carcinoma" (6 trials) and "Head and Neck Cancer" (5 trials). Many other conditions were trialed in "Highland Hospital" in a lesser frequency.

Most popular intervention types in "Highland Hospital" are "Drug" (97 trials), "Other" (61 trials), "Radiation" (61 trials), "Biological" (34 trials) and "Procedure" (19 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (30 trials), "Quality-of-Life Assessment" (24 trials), "Cisplatin" (16 trials), "Carboplatin" (13 trials) and "Paclitaxel" (13 trials). Other intervention names were less common.

The vast majority of trials in "Highland Hospital" are 79 trials for "All" genders, 33 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are NaN active trials in "Highland Hospital". undefined are not yet recruiting, 21 are recruiting, 37 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in Highland Hospital, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Highland Hospital, 5 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 77 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".